Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

464.50p
   
  • Change Today:
      6.00p
  • 52 Week High: 464.50p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 106.20m
  • Volume: 269,359
  • Market Cap: £493.30m
  • RiskGrade: 125
  • Beta: 0.02

Oxford Biomedica CEO John Dawson to step down

By Frank Prenesti

Date: Monday 17 Jan 2022

LONDON (ShareCast) - (Sharecast News) - Oxford Biomedica chief executive John Dawson said he was stepping down after 13 years at the helm of the Gene and cell therapy firm which helped develop a Covid-19 vaccine with AstraZeneca.
Dawson said he would "retire at the appropriate time".

"I believe this is the right time to start the transition to a new leader given the robustness of the senior team and company as a whole, which is undoubtedly stronger than ever before," he said in a statement.

Oxford Biomedica chairman Dr Roch Doliveux said it had started searching for Dawson's replacement to "lead the group through its next phase of growth".



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 464.50p
Change Today 6.00p
% Change 1.31 %
52 Week High 464.50p
52 Week Low 232.50p
Volume 269,359
Shares Issued 106.20m
Market Cap £493.30m
Beta 0.02
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.76% below the market average33.76% below the market average33.76% below the market average33.76% below the market average33.76% below the market average
25.58% above the sector average25.58% above the sector average25.58% above the sector average25.58% above the sector average25.58% above the sector average
Price Trend
13.48% below the market average13.48% below the market average13.48% below the market average13.48% below the market average13.48% below the market average
37.78% above the sector average37.78% above the sector average37.78% above the sector average37.78% above the sector average37.78% above the sector average
Income Not Available
Growth
4.57% above the market average4.57% above the market average4.57% above the market average4.57% above the market average4.57% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 01-Aug-2025

Time Volume / Share Price
17:08 1,700 @ 464.50p
16:35 30,180 @ 464.50p
16:35 8 @ 464.50p
16:35 15 @ 464.50p
16:35 797 @ 464.50p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page